drugset / Trial / NCT05886192

The Construction and Application of Therapeutic System of Intelligent Decision-Oriented Hemodynamic Organized Therapy for Shock Patients

NCT05886192

Phase 4 Unknown 60 enrolled Peking Union Medical College Hospital
RandomizedSingle-groupTriple-blindTreatment

Summary

Patients with septic shock with norepinephrine \>0.25ug/kg/min were enrolled. Informed consent was obtained for inclusion in the study and random assignment into the combination or norepinephrine group. Contact the research assistant to obtain patient number information and print out the appropriate labels.Notify the ward dispensing nurse to open the experimental drug cassette (placed in the refrigerator 4℃ drug cabinet). Extract the corresponding experimental medication according to the patient label number, dispense it and send it to the ward, label it and hand it over to the bedside nurse to start using it. The time point at which the medication was connected to the patient and activated was recorded as the zero point for the start of the study. The data were monitored according to the time points specified in the study: baseline,0h , 6h, D1, D2, and post-drug withdrawal.

Timeline

Start
2023-05-01
Primary completion
2025-01-01
Completion
2025-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide
Comparator Norepinephrine Other / unclassified